Cargando…

Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy

PURPOSE: The design, conduct and completion of randomized trials for curative prostate cancer (PCa) treatments are challenging. To evaluate the effect of robot-assisted radical prostatectomy (RARP) versus focal irreversible electroporation (IRE) on patient-reported quality of life (QoL) and early on...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheltema, Matthijs J., Chang, John I., Böhm, Maret, van den Bos, Willemien, Blazevski, Alexandar, Gielchinsky, Ilan, Kalsbeek, Anton M. F., van Leeuwen, Pim J., Nguyen, Tuan V., de Reijke, Theo M., Siriwardana, Amila R., Thompson, James E., de la Rosette, Jean J., Stricker, Phillip D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105143/
https://www.ncbi.nlm.nih.gov/pubmed/29594551
http://dx.doi.org/10.1007/s00345-018-2281-z
_version_ 1783349606301564928
author Scheltema, Matthijs J.
Chang, John I.
Böhm, Maret
van den Bos, Willemien
Blazevski, Alexandar
Gielchinsky, Ilan
Kalsbeek, Anton M. F.
van Leeuwen, Pim J.
Nguyen, Tuan V.
de Reijke, Theo M.
Siriwardana, Amila R.
Thompson, James E.
de la Rosette, Jean J.
Stricker, Phillip D.
author_facet Scheltema, Matthijs J.
Chang, John I.
Böhm, Maret
van den Bos, Willemien
Blazevski, Alexandar
Gielchinsky, Ilan
Kalsbeek, Anton M. F.
van Leeuwen, Pim J.
Nguyen, Tuan V.
de Reijke, Theo M.
Siriwardana, Amila R.
Thompson, James E.
de la Rosette, Jean J.
Stricker, Phillip D.
author_sort Scheltema, Matthijs J.
collection PubMed
description PURPOSE: The design, conduct and completion of randomized trials for curative prostate cancer (PCa) treatments are challenging. To evaluate the effect of robot-assisted radical prostatectomy (RARP) versus focal irreversible electroporation (IRE) on patient-reported quality of life (QoL) and early oncological control using propensity-scored matching. METHODS: Patients with T1c–cT2b significant PCa (high-volume ISUP 1 or any 2/3) who received unifocal IRE were pair-matched to patients who received nerve-sparing RARP. Patient-reported outcomes were prospectively assessed using the Expanded Prostate Cancer Index Composite (EPIC), AUA symptom score and Short Form of Health Survey (SF-12) physical and mental components. Oncological failure was defined as biochemical recurrence (RARP) or positive follow-up biopsies (IRE). Generalized mixed-effect models were used to compare IRE and RARP. RESULTS: 50 IRE patients were matched to 50 RARP patients by propensity score. IRE was significantly superior to RARP in preserving pad-free continence (UC) and erections sufficient for intercourse (ESI). The absolute differences were 44, 21, 13, 14% for UC and 32, 46, 27, 22% for ESI at 1.5, 3, 6, and 12 months, respectively. The EPIC summary scores showed no statistically significant differences. Urinary symptoms were reduced for IRE and RARP patients at 12 months, although IRE patient initially had more complaints. IRE patients experienced more early oncological failure than RARP patients. CONCLUSIONS: These data demonstrated the superior preservation of UC and ESI with IRE compared to RARP up to 12 months after treatment. Long-term oncological data are warranted to provide ultimate proof for or against focal therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00345-018-2281-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6105143
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-61051432018-08-30 Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy Scheltema, Matthijs J. Chang, John I. Böhm, Maret van den Bos, Willemien Blazevski, Alexandar Gielchinsky, Ilan Kalsbeek, Anton M. F. van Leeuwen, Pim J. Nguyen, Tuan V. de Reijke, Theo M. Siriwardana, Amila R. Thompson, James E. de la Rosette, Jean J. Stricker, Phillip D. World J Urol Original Article PURPOSE: The design, conduct and completion of randomized trials for curative prostate cancer (PCa) treatments are challenging. To evaluate the effect of robot-assisted radical prostatectomy (RARP) versus focal irreversible electroporation (IRE) on patient-reported quality of life (QoL) and early oncological control using propensity-scored matching. METHODS: Patients with T1c–cT2b significant PCa (high-volume ISUP 1 or any 2/3) who received unifocal IRE were pair-matched to patients who received nerve-sparing RARP. Patient-reported outcomes were prospectively assessed using the Expanded Prostate Cancer Index Composite (EPIC), AUA symptom score and Short Form of Health Survey (SF-12) physical and mental components. Oncological failure was defined as biochemical recurrence (RARP) or positive follow-up biopsies (IRE). Generalized mixed-effect models were used to compare IRE and RARP. RESULTS: 50 IRE patients were matched to 50 RARP patients by propensity score. IRE was significantly superior to RARP in preserving pad-free continence (UC) and erections sufficient for intercourse (ESI). The absolute differences were 44, 21, 13, 14% for UC and 32, 46, 27, 22% for ESI at 1.5, 3, 6, and 12 months, respectively. The EPIC summary scores showed no statistically significant differences. Urinary symptoms were reduced for IRE and RARP patients at 12 months, although IRE patient initially had more complaints. IRE patients experienced more early oncological failure than RARP patients. CONCLUSIONS: These data demonstrated the superior preservation of UC and ESI with IRE compared to RARP up to 12 months after treatment. Long-term oncological data are warranted to provide ultimate proof for or against focal therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00345-018-2281-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-03-28 2018 /pmc/articles/PMC6105143/ /pubmed/29594551 http://dx.doi.org/10.1007/s00345-018-2281-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Scheltema, Matthijs J.
Chang, John I.
Böhm, Maret
van den Bos, Willemien
Blazevski, Alexandar
Gielchinsky, Ilan
Kalsbeek, Anton M. F.
van Leeuwen, Pim J.
Nguyen, Tuan V.
de Reijke, Theo M.
Siriwardana, Amila R.
Thompson, James E.
de la Rosette, Jean J.
Stricker, Phillip D.
Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
title Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
title_full Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
title_fullStr Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
title_full_unstemmed Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
title_short Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
title_sort pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105143/
https://www.ncbi.nlm.nih.gov/pubmed/29594551
http://dx.doi.org/10.1007/s00345-018-2281-z
work_keys_str_mv AT scheltemamatthijsj pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT changjohni pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT bohmmaret pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT vandenboswillemien pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT blazevskialexandar pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT gielchinskyilan pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT kalsbeekantonmf pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT vanleeuwenpimj pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT nguyentuanv pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT dereijketheom pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT siriwardanaamilar pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT thompsonjamese pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT delarosettejeanj pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy
AT strickerphillipd pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy